| 000 | 01398 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513220303.0 | ||
| 264 | 0 | _c20001004 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0014-3022 | ||
| 024 | 7 |
_a10.1159/000008204 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJorga, K M | |
| 245 | 0 | 0 |
_aEffect of tolcapone on the haemodynamic effects and tolerability of desipramine. _h[electronic resource] |
| 260 |
_bEuropean neurology _c2000 |
||
| 300 |
_a94-103 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzophenones _xadverse effects |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDesipramine _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDrug Interactions _xphysiology |
| 650 | 0 | 4 |
_aDrug Tolerance _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNitrophenols |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aTolcapone |
| 700 | 1 | _aFotteler, B | |
| 700 | 1 | _aModi, M | |
| 700 | 1 | _aRabbia, M | |
| 773 | 0 |
_tEuropean neurology _gvol. 44 _gno. 2 _gp. 94-103 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000008204 _zAvailable from publisher's website |
| 999 |
_c10912629 _d10912629 |
||